A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib co-administered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF)
Administered By
Awarded By
Contributors
- Morrison, Lake Daniel Principal Investigator
Start/End
- November 1, 2016 - October 31, 2018